Countries/territories | GNI (US$) | Most recent edition of NEML (year) | Oral fludrocortisone | Oral hydrocortisone | Injectable hydrocortisone |
Low-income group | |||||
Somalia | 310 | 2020 | No | No | Yes |
Afghanistan | 500 | 2014 | No | No | Yes |
Sudan | 650 | 2019 | No | Yes | Yes |
Yemen | 940* | 2009 | No | No | Yes |
Syrian Arab Republic | 1820* | 2019 | No | No | Yes |
Lower-middle-income group | |||||
Pakistan† | 1280 | 2018 | Yes | Yes | Yes |
Iran (Islamic Republic of) | 2870 | 2009 | Yes | Yes | Yes |
Morocco | 2980 | 2021 (ongoing) | No | Yes | Yes |
Egypt (Arab Republic) | 3000 | 2018–2019 | Yes | Yes | Yes |
Tunisia | 3100 | 2021 (online) | Yes | Yes | Yes |
Djibouti | 3320 | 2007 | No | No | Yes |
Algeria | 3550 | 2019 | No | Yes | Yes |
Occupied Territory of Palestine | 3710 | 2021 (ongoing) | Yes | Yes | Yes |
Upper-middle-income group | |||||
Jordan | 4310 | 2011 | Yes | Yes | Yes |
Iraq | 4660 | 2010 | Yes | Yes | Yes |
Libya | 4850 | 2019 | Yes | Yes | Yes |
Lebanon | 5510 | 2018 | No | Yes | Yes |
High-income group | |||||
Oman | 14 150* | 2016 | Yes | Yes | Yes |
Saudi Arabia | 21 930 | 2018 | Yes | Yes ‡ | Yes |
Bahrain | 22 170* | 2015 | Yes | Yes | Yes |
Kuwait§ | 33 290* | WHO EML | Yes | Yes | Yes |
United Arab Emirates | 43 470* | 2021 | Yes | Yes | Yes |
Qatar | 56 210 | 2021 (ongoing) | No | Yes | Yes |
*Gross National Income (GNI) per capita (Atlas Method23 was last updated in 2020, except for the Syrian Arab Republic (2007), Yemen (2018) and Bahrain, Kuwait, Oman and United Arab Emirates (2019).
†Hydrocortisone tablets are not included in the most recent NEML for Pakistan, but they are now readily available and are expected to be included in the next edition.
‡Hydrocortisone is not included in the most recent NEML for Saudi Arabia, but it is included in the registration database. This will be updated in the next edition of the NEML.
§Kuwait uses the WHO EML but is considering the development of a NEML.35
NEML, National List of Essential Medicines.